Form 4: ALX Oncology SVP, Finance and CAO, Shelly Pinto, Reports Sale of Common Stock
SEC Form 4
Shelly Pinto, SVP, Finance and CAO of ALX Oncology Holdings Inc, reports the sale of 1,823 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On July 5, 2024, Shelly Pinto, SVP, Finance and CAO of ALX Oncology Holdings Inc, sold 1,823 shares of common stock.
- The sale was executed at a weighted average price of $5.4993 per share, with individual transactions ranging from $5.45 to $5.50.
- The purpose of the sale was to satisfy tax obligations related to the vesting of restricted stock units.
- Following the transaction, Pinto directly owns 92,113 shares of ALX Oncology Holdings Inc.
- The transaction was reported on July 9, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment. The filing reflects a routine transaction to cover tax obligations, with no indication of positive or negative sentiment towards the company's prospects.
Industry Context
This is a routine disclosure of an insider stock sale, common for executives to cover tax obligations related to equity compensation. It doesn't necessarily reflect a negative outlook on the company.
Stakeholder Impact
- The sale of shares by an executive could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 07/05/2024 | Date of transaction: Shelly Pinto sold 1,823 shares of common stock. |
| 07/09/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.